HIV-1 Rev and related inhibitors

Yaoxue Xuebao

Volumn 42, Issue 4, 2007, Pages 347-351

  Cao, Yuan ^a   Liu, Xin Yong ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

HIV 1; Inhibitors; Rev; Transcription

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CELL RECEPTOR; EXPORTIN 1 PROTEIN; FRAMYCETIN; KARYOPHERIN; LEPTOMYCIN B; MESSENGER RNA; REV PROTEIN; REV PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; REV PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS-1; UNSATURATED FATTY ACID; VIRUS RNA;

ACTIVE TRANSPORT; AMINO ACID SEQUENCE; ARTICLE; CELL NUCLEUS; CHEMISTRY; DRUG ANTAGONISM; GENETIC TRANSCRIPTION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PHYSIOLOGY; VIRUS REPLICATION;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; ANTI-HIV AGENTS; CELL NUCLEUS; FATTY ACIDS, UNSATURATED; FRAMYCETIN; HIV-1; KARYOPHERINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; RNA, MESSENGER; RNA, VIRAL; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 34249880552     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bai RJ, Liu XY. Transactivation of HIV-1 transcription and inhibitors [J]. Acta Pharm Sin, 2006, 41:289-295.
2. Turpin JA. The next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets [J]. Expert Rev Anti-infect Ther, 2003, 1:97 - 128.
3. Agrawal L, Lu X, Jin Q, el al. Anti-HIV therapy: current and future directions [J]. Curr Pharm Des, 2006, 12:2031 -2055.
4. Cochrane A. Controlling HIV-1 Rev function [J]. Curr Drug Targets Immune Endocr Metabol Disord, 2004, 4: 287-295.
5. Cullen BR. Nuclear mRNA export: insights from virology [J]. Trends Biochem Sci, 2003, 8:419 - 424.
6. Weis K. Nucleocytoplasmic transport: cargo trafficking across the border [J]. Curr Opin Cell Biol, 2002, 14: 328-335.
7. Nakatani K, Horie S, Goto Y, et al. Evaluation of mismatch-binding ligands as inhibitors for Rev-RRE interaction [J]. Bioorg Med Chem, 2006, 14:5384 - 5388.
8. Lesnik EA, Sampath R, Ecker DJ. Rev response elements (RRE) in lentiviruses: an RNAMotif algorithm-based strategy for RRE prediction [J]. Med Res Rev, 2002, 22:617 - 636.
9. Surendran R, Herman P, Cheng Z, et al. HIV Rev self-assembly is linked to a molten-globule to compact structural transition [J]. Biophys Chem, 2004, 108: 101 - 119.
10. Favaro JP, Borg KT, Arrigo SJ, et al. Effect of Rev on the intranuclear localization of HIV-1 unspliced RNA [J]. Virology, 1998, 249:286 - 296.
11. Perales C, Carrasco L, Gonzalez ME. Regulation of HIV-1 env mRNA translation by Rev protein [J]. Biochim Biophys Acta, 2005, 1743:169 - 175.
12. Hope TJ. The ins and outs of HIV Rev [J]. Arch Biochem Biophys, 1999, 365:186 - 191.
13. Izaurralde E, Adam S. Transport of macromolecules between the nucleus and the cytoplasm [J]. RNA, 1998, 4:351 - 364.
14. Arnold M, Nath A, Hauber J, et al. Multiple importins function as nuclear transport receptors for the Rev protein of human immunodeficiency virus type 1 [J]. J Biol Chem, 2006, 281:20883 - 20890.
15. Kudo N, Wolff B, Sekimoto T, et al. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1 [J]. Exp Cell Res, 1998, 242:540 - 547.
16. Daelemans D, Afonina E, Nilsson J, et al. A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export [J]. Proc Natl Acad Sci USA, 2002, 99: 14440 - 14445.
17. De Clercq E. New approaches toward anti-HIV chemotherapy [J]. J Med Chem, 2005, 48:1297 - 1313.
18. Chapman RL, Stanley TB, Hazen R, et al. Small molecule modulators of HIV Rev/Rev response element interaction identified by random screening [J]. Antiviral Res, 2002, 54:149 - 162.
19. Baba M. Inhibitors of HIV-1 gene expression and transcription [J]. Curr Top Med Chem, 2004, 4:871 - 882.
20. Dejong ES, Chang CE, Gilson MK, et al. Proflavine acts as a Rev inhibitor by targeting the high-affinity Rev binding site of the Rev responsive element of HIV-1 [J]. Biochemistry, 2003, 42:8035 - 8046.
21. Li K, Davis TM, Bailly C, et al. A Heterocyclic inhibitor of the Rev-RRE complex binds to RRE as a dimer [J]. Biochemistry, 2001, 40:1150-1158.
22. Jeong KS, N am YS, Venkatesan S. Deletions near the N-terminus of HIV-1 Rev reduce RNA binding affinity and dominantly interfere with Rev function irrespective of the RNA target [J]. Arch Virol, 2000, 145:2443 - 2467.
23. Trikha R, Brighty DW. Phenotypic analysis of human immunodeficiency virus type 1 Rev trimerization-interface mutants in human cells [J]. J Gen Virol, 2005, 86: 1509-1513.